0001822966 12-31 2024 Q3 false 100 33.33 33.33 xbrli:shares iso4217:USD iso4217:USD xbrli:shares utr:MW smr:employee xbrli:pure smr:day smr:plaintiff 0001822966 2024-01-01 2024-09-30 0001822966 us-gaap:CommonClassAMember 2024-01-01 2024-09-30 0001822966 us-gaap:WarrantMember 2024-01-01 2024-09-30 0001822966 us-gaap:CommonClassAMember 2024-11-04 0001822966 us-gaap:CommonClassBMember 2024-11-04 0001822966 2024-09-30 0001822966 2023-12-31 0001822966 us-gaap:CommonClassAMember 2023-12-31 0001822966 us-gaap:CommonClassAMember 2024-09-30 0001822966 us-gaap:CommonClassBMember 2023-12-31 0001822966 us-gaap:CommonClassBMember 2024-09-30 0001822966 2024-07-01 2024-09-30 0001822966 2023-07-01 2023-09-30 0001822966 2023-01-01 2023-09-30 0001822966 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2024-06-30 0001822966 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2024-06-30 0001822966 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001822966 us-gaap:RetainedEarningsMember 2024-06-30 0001822966 us-gaap:NoncontrollingInterestMember 2024-06-30 0001822966 2024-06-30 0001822966 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001822966 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2024-07-01 2024-09-30 0001822966 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2024-07-01 2024-09-30 0001822966 us-gaap:NoncontrollingInterestMember 2024-07-01 2024-09-30 0001822966 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001822966 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2024-09-30 0001822966 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2024-09-30 0001822966 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001822966 us-gaap:RetainedEarningsMember 2024-09-30 0001822966 us-gaap:NoncontrollingInterestMember 2024-09-30 0001822966 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-12-31 0001822966 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2023-12-31 0001822966 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001822966 us-gaap:RetainedEarningsMember 2023-12-31 0001822966 us-gaap:NoncontrollingInterestMember 2023-12-31 0001822966 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-09-30 0001822966 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2024-01-01 2024-09-30 0001822966 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2024-01-01 2024-09-30 0001822966 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-09-30 0001822966 us-gaap:RetainedEarningsMember 2024-01-01 2024-09-30 0001822966 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-06-30 0001822966 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2023-06-30 0001822966 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001822966 us-gaap:RetainedEarningsMember 2023-06-30 0001822966 us-gaap:NoncontrollingInterestMember 2023-06-30 0001822966 2023-06-30 0001822966 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001822966 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-07-01 2023-09-30 0001822966 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2023-07-01 2023-09-30 0001822966 us-gaap:NoncontrollingInterestMember 2023-07-01 2023-09-30 0001822966 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001822966 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-09-30 0001822966 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2023-09-30 0001822966 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001822966 us-gaap:RetainedEarningsMember 2023-09-30 0001822966 us-gaap:NoncontrollingInterestMember 2023-09-30 0001822966 2023-09-30 0001822966 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-12-31 0001822966 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2022-12-31 0001822966 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001822966 us-gaap:RetainedEarningsMember 2022-12-31 0001822966 us-gaap:NoncontrollingInterestMember 2022-12-31 0001822966 2022-12-31 0001822966 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0001822966 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001822966 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2023-01-01 2023-09-30 0001822966 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-09-30 0001822966 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0001822966 2024-01-05 2024-01-05 0001822966 2024-01-05 0001822966 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember 2023-01-01 2023-09-30 0001822966 us-gaap:GovernmentMember smr:UnitedStateTradeAndDevelopmentAgencyMember 2024-07-01 2024-09-30 0001822966 us-gaap:GovernmentMember smr:UnitedStateTradeAndDevelopmentAgencyMember 2023-07-01 2023-09-30 0001822966 us-gaap:GovernmentMember smr:UnitedStateTradeAndDevelopmentAgencyMember 2024-01-01 2024-09-30 0001822966 us-gaap:GovernmentMember smr:UnitedStateTradeAndDevelopmentAgencyMember 2023-01-01 2023-09-30 0001822966 smr:NuscaleSMRFOAKNuclearDemonstrationReadinessProjectCompletionMember 2024-01-01 2024-09-30 0001822966 smr:NuscaleSMRFOAKNuclearDemonstrationReadinessProjectCompletionMember 2023-07-01 2023-09-30 0001822966 smr:NuscaleSMRFOAKNuclearDemonstrationReadinessProjectCompletionMember 2023-01-01 2023-09-30 0001822966 us-gaap:GovernmentMember smr:CFPPLLCMember 2024-07-01 2024-09-30 0001822966 us-gaap:GovernmentMember smr:CFPPLLCMember 2023-07-01 2023-09-30 0001822966 us-gaap:GovernmentMember smr:CFPPLLCMember 2024-01-01 2024-09-30 0001822966 us-gaap:GovernmentMember smr:CFPPLLCMember 2023-01-01 2023-09-30 0001822966 us-gaap:CommonClassAMember 2024-06-30 0001822966 us-gaap:CommonClassAMember 2023-06-30 0001822966 us-gaap:CommonClassAMember 2022-12-31 0001822966 us-gaap:CommonClassAMember 2024-07-01 2024-09-30 0001822966 us-gaap:CommonClassAMember 2023-07-01 2023-09-30 0001822966 us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001822966 us-gaap:CommonClassAMember 2023-09-30 0001822966 us-gaap:CommonClassBMember 2024-06-30 0001822966 us-gaap:CommonClassBMember 2023-06-30 0001822966 us-gaap:CommonClassBMember 2022-12-31 0001822966 us-gaap:CommonClassBMember 2024-07-01 2024-09-30 0001822966 us-gaap:CommonClassBMember 2023-07-01 2023-09-30 0001822966 us-gaap:CommonClassBMember 2024-01-01 2024-09-30 0001822966 us-gaap:CommonClassBMember 2023-01-01 2023-09-30 0001822966 us-gaap:CommonClassBMember 2023-09-30 0001822966 smr:NuScaleCorpMember us-gaap:CommonClassAMember 2024-06-30 0001822966 smr:NuScaleCorpMember us-gaap:CommonClassAMember 2023-06-30 0001822966 smr:NuScaleCorpMember us-gaap:CommonClassAMember 2023-12-31 0001822966 smr:NuScaleCorpMember us-gaap:CommonClassAMember 2022-12-31 0001822966 smr:NuScaleCorpMember us-gaap:CommonClassAMember 2024-09-30 0001822966 smr:NuScaleCorpMember us-gaap:CommonClassAMember 2023-09-30 0001822966 smr:NuScaleLLCMember us-gaap:CommonClassBMember 2024-06-30 0001822966 smr:NuScaleLLCMember us-gaap:CommonClassBMember 2023-06-30 0001822966 smr:NuScaleLLCMember us-gaap:CommonClassBMember 2023-12-31 0001822966 smr:NuScaleLLCMember us-gaap:CommonClassBMember 2022-12-31 0001822966 smr:NuScaleLLCMember us-gaap:CommonClassBMember 2024-09-30 0001822966 smr:NuScaleLLCMember us-gaap:CommonClassBMember 2023-09-30 0001822966 smr:ClassBCommonSharesMember 2024-07-01 2024-09-30 0001822966 smr:ClassBCommonSharesMember 2023-07-01 2023-09-30 0001822966 smr:ClassBCommonSharesMember 2024-01-01 2024-09-30 0001822966 smr:ClassBCommonSharesMember 2023-01-01 2023-09-30 0001822966 us-gaap:StockOptionMember 2024-07-01 2024-09-30 0001822966 us-gaap:StockOptionMember 2023-07-01 2023-09-30 0001822966 us-gaap:StockOptionMember 2024-01-01 2024-09-30 0001822966 us-gaap:StockOptionMember 2023-01-01 2023-09-30 0001822966 us-gaap:WarrantMember 2024-07-01 2024-09-30 0001822966 us-gaap:WarrantMember 2023-07-01 2023-09-30 0001822966 us-gaap:WarrantMember 2024-01-01 2024-09-30 0001822966 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001822966 us-gaap:RestrictedStockUnitsRSUMember 2024-07-01 2024-09-30 0001822966 us-gaap:RestrictedStockUnitsRSUMember 2023-07-01 2023-09-30 0001822966 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-09-30 0001822966 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-09-30 0001822966 us-gaap:CommonClassAMember smr:ATMProgramMember 2024-07-01 2024-09-30 0001822966 us-gaap:CommonClassAMember smr:ATMProgramMember 2024-01-01 2024-09-30 0001822966 us-gaap:CommonClassAMember smr:ATMProgramMember 2023-07-01 2023-09-30 0001822966 us-gaap:CommonClassAMember smr:ATMProgramMember 2023-01-01 2023-09-30 0001822966 us-gaap:CommonClassAMember smr:ATMProgramMember 2024-09-30 0001822966 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember smr:ATMProgramMember 2024-10-01 2024-11-08 0001822966 smr:PublicWarrantMember 2024-09-30 0001822966 smr:PublicWarrantMember 2024-01-01 2024-09-30 0001822966 smr:PublicWarrantMember 2024-07-01 2024-09-30 0001822966 smr:WarrantRedemptionScenarioOneMember 2024-09-30 0001822966 smr:WarrantRedemptionScenarioOneMember 2024-01-01 2024-09-30 0001822966 smr:WarrantRedemptionScenarioTwoMember 2024-09-30 0001822966 smr:WarrantRedemptionScenarioTwoMember 2024-01-01 2024-09-30 0001822966 smr:PublicWarrantMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-09-30 0001822966 smr:PublicWarrantMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-09-30 0001822966 smr:PublicWarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-09-30 0001822966 smr:PublicWarrantMember us-gaap:FairValueMeasurementsRecurringMember 2024-09-30 0001822966 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-09-30 0001822966 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-09-30 0001822966 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-09-30 0001822966 us-gaap:FairValueMeasurementsRecurringMember 2024-09-30 0001822966 smr:PublicWarrantMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001822966 smr:PublicWarrantMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001822966 smr:PublicWarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001822966 smr:PublicWarrantMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001822966 smr:PrivatePlacementWarrantMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001822966 smr:PrivatePlacementWarrantMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001822966 smr:PrivatePlacementWarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001822966 smr:PrivatePlacementWarrantMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001822966 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001822966 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001822966 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001822966 us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001822966 us-gaap:FurnitureAndFixturesMember 2024-09-30 0001822966 us-gaap:FurnitureAndFixturesMember 2023-12-31 0001822966 smr:OfficeAndComputerEquipmentMember 2024-09-30 0001822966 smr:OfficeAndComputerEquipmentMember 2023-12-31 0001822966 us-gaap:SoftwareDevelopmentMember 2024-09-30 0001822966 us-gaap:SoftwareDevelopmentMember 2023-12-31 0001822966 us-gaap:TechnologyEquipmentMember 2024-09-30 0001822966 us-gaap:TechnologyEquipmentMember 2023-12-31 0001822966 us-gaap:LeaseholdImprovementsMember 2024-09-30 0001822966 us-gaap:LeaseholdImprovementsMember 2023-12-31 0001822966 smr:DepreciablePropertyPlantAndEquipmentMember 2024-09-30 0001822966 smr:DepreciablePropertyPlantAndEquipmentMember 2023-12-31 0001822966 us-gaap:GeneralAndAdministrativeExpenseMember 2024-07-01 2024-09-30 0001822966 us-gaap:OtherExpenseMember 2024-07-01 2024-09-30 0001822966 us-gaap:GeneralAndAdministrativeExpenseMember 2023-07-01 2023-09-30 0001822966 us-gaap:OtherExpenseMember 2023-07-01 2023-09-30 0001822966 us-gaap:GeneralAndAdministrativeExpenseMember 2024-01-01 2024-09-30 0001822966 us-gaap:OtherExpenseMember 2024-01-01 2024-09-30 0001822966 us-gaap:GeneralAndAdministrativeExpenseMember 2023-01-01 2023-09-30 0001822966 us-gaap:OtherExpenseMember 2023-01-01 2023-09-30 0001822966 smr:CFPPLLCMember smr:LongLeadMaterialContractMember 2023-03-31 0001822966 smr:CFPPLLCMember smr:LongLeadMaterialContractMember 2023-11-07 0001822966 smr:CFPPLLCMember smr:LongLeadMaterialContractMember 2024-09-30 0001822966 smr:CFPPLLCMember smr:LongLeadMaterialContractMember 2023-12-31 0001822966 smr:OneLLMManufacturingVendorMember 2024-09-30 0001822966 smr:DefinedContributionPlanTrancheOneMember 2024-01-01 2024-09-30 0001822966 smr:DefinedContributionPlanTrancheTwoMember 2024-01-01 2024-09-30 0001822966 smr:RomanianTaxAuthorityMember 2024-09-30 0001822966 us-gaap:EmployeeStockOptionMember 2024-07-01 2024-09-30 0001822966 us-gaap:EmployeeStockOptionMember 2023-07-01 2023-09-30 0001822966 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-09-30 0001822966 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-09-30 0001822966 us-gaap:EmployeeStockOptionMember us-gaap:GeneralAndAdministrativeExpenseMember 2024-07-01 2024-09-30 0001822966 us-gaap:EmployeeStockOptionMember us-gaap:OtherExpenseMember 2024-07-01 2024-09-30 0001822966 us-gaap:EmployeeStockOptionMember us-gaap:GeneralAndAdministrativeExpenseMember 2023-07-01 2023-09-30 0001822966 us-gaap:EmployeeStockOptionMember us-gaap:OtherExpenseMember 2023-07-01 2023-09-30 0001822966 us-gaap:EmployeeStockOptionMember us-gaap:GeneralAndAdministrativeExpenseMember 2024-01-01 2024-09-30 0001822966 us-gaap:EmployeeStockOptionMember us-gaap:OtherExpenseMember 2024-01-01 2024-09-30 0001822966 us-gaap:EmployeeStockOptionMember us-gaap:GeneralAndAdministrativeExpenseMember 2023-01-01 2023-09-30 0001822966 us-gaap:EmployeeStockOptionMember us-gaap:OtherExpenseMember 2023-01-01 2023-09-30 0001822966 us-gaap:EmployeeStockOptionMember 2024-09-30 0001822966 us-gaap:RestrictedStockUnitsRSUMember 2024-09-30 0001822966 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-09-30 0001822966 smr:ServicesPerformedMember 2024-07-01 2024-09-30 0001822966 smr:ServicesPerformedMember 2023-07-01 2023-09-30 0001822966 smr:ServicesPerformedMember 2024-01-01 2024-09-30 0001822966 smr:ServicesPerformedMember 2023-01-01 2023-09-30 0001822966 us-gaap:RelatedPartyMember 2024-09-30 0001822966 us-gaap:RelatedPartyMember 2023-12-31 0001822966 us-gaap:RelatedPartyMember 2024-07-01 2024-09-30 0001822966 us-gaap:RelatedPartyMember 2023-07-01 2023-09-30 0001822966 us-gaap:RelatedPartyMember 2024-01-01 2024-09-30 0001822966 us-gaap:RelatedPartyMember 2023-01-01 2023-09-30 0001822966 us-gaap:RelatedPartyMember smr:FluorMember 2024-07-01 2024-09-30 0001822966 us-gaap:RelatedPartyMember smr:FluorMember 2023-07-01 2023-09-30 0001822966 us-gaap:RelatedPartyMember smr:FluorMember 2024-01-01 2024-09-30 0001822966 us-gaap:RelatedPartyMember smr:FluorMember 2023-01-01 2023-09-30 0001822966 2022-09-19 2022-09-19 0001822966 smr:KarinFeldmanMember 2024-01-01 2024-09-30 0001822966 smr:JackieEngelMember 2024-07-01 2024-09-30 0001822966 smr:JohnHopkinsMember 2024-07-01 2024-09-30 0001822966 smr:R.RamseyHamadyMember 2024-07-01 2024-09-30 0001822966 smr:KarinFeldmanMember 2024-07-01 2024-09-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________
FORM 10-Q
______________________
(Mark One)

☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2024
OR

☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____________ to ____________
Commission file number 001-04321
______________________
NUSCALE POWER CORPORATION
(Exact name of registrant as specified in its charter)
______________________

Delaware |  |  | 98-1588588
(State or other jurisdiction of incorporation or organization) |  |  | (I.R.S. Employer Identification No.)
1100 NE Circle Blvd., Suite 200 | Corvallis | Oregon | 97330
(Address of Principal Executive Offices) |  |  | (Zip Code)

(971) 371-1592
Registrant's telephone number, including area code
Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol(s) | Name of each exchange on which registered
Class A common stock, $0.0001 par value per share | SMR | New York Stock Exchange
Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share | SMR.WS | New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer | o | Accelerated filer | ☑
Non-accelerated filer | o | Smaller reporting company | ☐
|  | Emerging growth company | ☑

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes o No x
APPLICABLE ONLY TO CORPORATE ISSUERS:
The registrant had 101,097,113 Class A common shares, $0.0001 par value, and 154,266,400 Class B common shares, $0.0001 par value, outstanding as of November 4, 2024.

Table of Contents

|  | Page Number
Glossary of Terms |
Cautionary Note Regarding Forward-Looking Statements |
Part I - Financial Information |
Item 1. | Financial Statements | 1
Item 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations | 17
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 20
Item 4. | Controls and Procedures | 21
Part II - Other Information |
Item 1. | Legal Proceedings | 22
Item 1A. | Risk Factors | 22
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 23
Item 3. | Defaults Upon Senior Securities | 23
Item 4. | Mine Safety Disclosures | 23
Item 5. | Other Information | 23
Item 6. | Exhibits | 24
Signatures | 25

Glossary
The definitions and abbreviations set forth below apply to the indicated terms used throughout this filing.
• “ATM Program” refers to the program, implemented in connection with the Sales Agreement, dated August 9, 2023, between NuScale Power Corporation, Cowen & Company, LLC, B. Riley Securities, Inc. and Canaccord Genuity LLC as sales agents, under which the Company may offer and sell shares of the Company’s Class A common stock having an aggregate sales price of up to $150,000,000 from time to time
• “CFPP LLC” refers to Carbon Free Power Project, LLC, an entity wholly owned by UAMPS.
• “CFPP” refers to the Carbon Free Power Project.
• “Class A common stock” refers to shares of Class A common stock, par value $0.0001 per share, of NuScale Power Corporation.
• “Class B common stock” refers to shares of Class B common stock, par value $0.0001 per share, of NuScale Power Corporation, which represents the right to one vote per share and carries no economic rights.
• “Combined interests” refers to the combination of shares of Class B common stock and NuScale LLC Class B units required to be exchanged for Class A common stock.
• “Common stock” refers collectively to shares of Class A common stock and Class B common stock.
• “DCA” refers to Design Certification Application
• “DCRA” refers to the Development Cost Reimbursement Agreement, as amended, entered into with CFPP LLC
• “DOE” refers to the U.S. Department of Energy.
• “Exchange Act” refers to the Securities Exchange Act of 1934, as amended.
• “Fluor” refers to Fluor Enterprises, Inc., a California corporation, which is wholly owned by Fluor
Corporation (NYSE: FLR).
• “GAAP” refers to United States Generally Accepted Accounting Principles.
• “G&A” expenses refers to general and administrative expenses.
• “IPO” or “Initial Public Offering” refers to the initial public offering of Spring Valley, which closed on
November 27, 2020.
• “Legacy NuScale Equityholders” refers to the holders of NuScale LLC Class B units.
• “LLM Agreement” refers to the Long Lead Material Reimbursement Agreement, dated February 28, 2023, entered into between NuScale LLC and CFPP LLC.
• “Merger” refers to the merger of Merger Sub with and into NuScale LLC, with NuScale LLC as the surviving entity.
• “Merger Agreement” refers to the Agreement and Plan of Merger, dated as of December 13, 2021 (as amended, modified, supplemented or waived from time to time), between Spring Valley, Merger Sub and NuScale LLC.
• “Merger Sub” refers to Spring Valley Merger Sub, LLC, an Oregon limited liability company and a
wholly owned subsidiary of Spring Valley.
• “MWe” refers to one million watts of electric power.
• “NPM” refers to NuScale Power Module™.
• “NRC” refers to the U.S. Nuclear Regulatory Commission.
• “NuScale Corp” refers to NuScale Power Corporation, a Delaware corporation and the combined company following the consummation of the Transaction, and its consolidated subsidiaries, including NuScale LLC.
• “NuScale LLC” refers to NuScale Power, LLC, an Oregon limited liability company.
• “NuScale LLC Class B Units” refers to non-voting, Class B units of NuScale LLC.
• “Private Placement Warrants” refers to the 8,900,000 warrants to purchase Spring Valley Class A ordinary shares that
were issued in a private placement concurrently with the IPO and converted in the Transaction into warrants to purchase Class A common stock.
• “Public Warrants” refers to the 11,500,000 redeemable warrants to purchase Spring Valley Class A ordinary shares that were issued in the IPO and converted in the Transaction
into warrants to purchase Class A common stock.
• “R&D” refers to research and development.
• “RSUs” refers to restricted stock units.
• “Release Agreement” refers to the Confidential Settlement and Release Agreement, dated November 7, 2023, entered into between NuScale LLC and CFPP LLC.
• “SDA” refers to Standard Design Approval.
• “SMR” refers to small modular reactor.
• “Spring Valley” refers to NuScale Corp prior to the Merger and prior to the change of its name from Spring Valley Acquisition Corp. to NuScale Power Corporation.
• “Tax Receivable Agreement” or “TRA” refers to the tax receivable agreement entered into concurrently with the consummation of the Transaction between NuScale Corp, NuScale LLC and the Legacy NuScale Equityholders.
• “Transaction” refers to the transactions contemplated by the Merger Agreement during the 2022 fiscal year.
• “UAMPS” refers to the Utah Associated Municipal Power Systems.
• “Warrant Agreement” refers to the Warrant Agreement, dated November 23, 2020, by and between Spring Valley and Continental Stock Transfer & Trust Company.
• “Warrants” refers collectively to the Public Warrants and the Private Placement Warrants.

Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q includes “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q, including, without limitation, statements regarding our financial position and business strategy and the expectations, beliefs, intentions, plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “continue,” “could,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “will,” “would,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this Quarterly Report may include, for example, statements about:
•our need for and ability to obtain additional equity financing or other sources of funding;
•our financial and business performance, including financial projections and business metrics;
•the ability to obtain regulatory approvals to deploy our SMRs in the United States and abroad;
•forecasts regarding end-customer adoption rates and demand for our products in markets that are new and rapidly evolving;
•macroeconomic conditions;
•developments and projections relating to our competitors and industry;
•our anticipated growth rates and market opportunities;
•litigation contingencies;
•the estimated amounts to be reimbursed to CFPP LLC and costs related to termination of the DCRA and LLM Agreement;
•our estimates regarding expenses, future revenue, capital requirements and needs for additional financing; and
•the potential for our business development efforts to maximize the potential value of our portfolio.
Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. Many factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, and there can be no assurance that future developments affecting us will be those we have anticipated.
Important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, are described in the section titled “Risk Factors” included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (“2023 Form 10-K”). If one or more of those risks or uncertainties materialize, or if any of our assumptions prove incorrect, actual results may vary in material respects from those projected in those forward-looking statements. There may be additional risks that we currently consider immaterial, or which are unknown. It is not possible to predict or identify all such risks. Except as expressly required by applicable securities law, we disclaim any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise. No person should take any statement regarding past trends or activities as a representation that the trends or activities will continue in the future.

Part I - Financial Information
Item 1. Financial Statements
NuScale Power Corporation
Condensed Consolidated Balance Sheet

(in thousands, except share and per share amounts) |  | September 30, 2024 |  | December 31, 2023
ASSETS |  | (Unaudited) |  |
Current Assets |  |  |  |
Cash and cash equivalents |  | $ | 111,628 |  |  | $ | 120,265 |
Short-term investments |  | 45,000 |  |  | — |
Restricted cash |  | 5,100 |  |  | 5,100 |
Prepaid expenses |  | 10,914 |  |  | 19,054 |
Accounts and other receivables, net |  | 7,912 |  |  | 10,127 |
Total current assets |  | 180,554 |  |  | 154,546 |
Property, plant and equipment, net |  | 2,756 |  |  | 4,116 |
In-process research and development |  | 16,900 |  |  | 16,900 |
Intangible assets, net |  | 749 |  |  | 882 |
Goodwill |  | 8,255 |  |  | 8,255 |
Long-lead material work in process |  | 41,609 |  |  | 36,361 |
Other assets |  | 2,461 |  |  | 3,798 |
Total Assets |  | $ | 253,284 |  |  | $ | 224,858 |
LIABILITIES AND EQUITY |  |  |  |
Current Liabilities |  |  |  |
Accounts payable and accrued expenses |  | $ | 17,897 |  |  | $ | 44,925 |
Accrued compensation |  | 7,749 |  |  | 8,546 |
Long-lead material liability |  | 33,064 |  |  | 32,323 |
Customer deposit |  | 20,000 |  |  | — |
Other accrued liabilities |  | 1,848 |  |  | 1,664 |
Total current liabilities |  | 80,558 |  |  | 87,458 |
Warrant liabilities |  | 58,681 |  |  | 5,722 |
Noncurrent accounts payable and accrued expenses |  | 23,604 |  |  | — |
Other noncurrent liabilities |  | 238 |  |  | 1,442 |
Deferred revenue |  | 78 |  |  | 898 |
Total Liabilities |  | 163,159 |  |  | 95,520 |
Stockholders’ Equity |  |  |  |
Class A common stock, par value $0.0001 per share, 332,000,000 shares authorized, 97,893,884 and 76,895,166 shares outstanding as of September 30, 2024 and December 31, 2023, respectively |  | 10 |  |  | 8 |
Class B common stock, par value $0.0001 per share, 179,000,000 shares authorized, 154,266,400 and 154,477,032 shares outstanding as of September 30, 2024 and December 31, 2023, respectively |  | 15 |  |  | 15 |
Additional paid-in capital |  | 462,146 |  |  | 333,888 |
Accumulated deficit |  | (302,102) |  |  | (240,454) |
Total Stockholders’ Equity Excluding Noncontrolling Interests |  | 160,069 |  |  | 93,457 |
Noncontrolling interests |  | (69,944) |  |  | 35,881 |
Total Stockholders' Equity |  | 90,125 |  |  | 129,338 |
Total Liabilities and Stockholders' Equity |  | $ | 253,284 |  |  | $ | 224,858 |

The accompanying notes are an integral part of these financial statements.
1

NuScale Power Corporation
Condensed Consolidated Statements of Operations
(Unaudited)

(in thousands, except share and per share amounts) |  | Three Months Ended September 30, |  | Nine Months Ended September 30,
|  | 2024 |  | 2023 |  | 2024 |  | 2023
Revenue |  | $ | 475 |  |  | $ | 6,950 |  |  | $ | 2,821 |  |  | $ | 18,250 |
Cost of sales |  | (295) |  |  | (5,940) |  |  | (1,880) |  |  | (15,121) |
Gross Margin |  | 180 |  |  | 1,010 |  |  | 941 |  |  | 3,129 |
Research and development expenses |  | 12,160 |  |  | 63,725 |  |  | 37,447 |  |  | 118,227 |
General and administrative expenses |  | 17,021 |  |  | 16,402 |  |  | 53,207 |  |  | 47,420 |
Other expenses |  | 12,018 |  |  | 13,799 |  |  | 37,157 |  |  | 41,991 |
Loss From Operations |  | (41,019) |  |  | (92,916) |  |  | (126,870) |  |  | (204,509) |
Sponsored cost share |  | 660 |  |  | 20,774 |  |  | 6,504 |  |  | 54,984 |
Change in fair value of warrant liabilities |  | (7,191) |  |  | 11,076 |  |  | (52,969) |  |  | 17,167 |
Interest income |  | 2,008 |  |  | 2,738 |  |  | 5,275 |  |  | 8,686 |
Loss Before Income Taxes |  | (45,542) |  |  | (58,328) |  |  | (168,060) |  |  | (123,672) |
Foreign income taxes |  | 12 |  |  | — |  |  | 12 |  |  | — |
Net Loss |  | (45,554) |  |  | (58,328) |  |  | (168,072) |  |  | (123,672) |
Net loss attributable to noncontrolling interests |  | (28,095) |  |  | (39,206) |  |  | (106,424) |  |  | (84,065) |
Net Loss Attributable to Class A Common Stockholders |  | $ | (17,459) |  |  | $ | (19,122) |  |  | $ | (61,648) |  |  | $ | (39,607) |
Loss per Share of Class A Common Stock: |  |  |  |  |  |  |  |
Basic and Diluted |  | $ | (0.18) |  |  | $ | (0.26) |  |  | $ | (0.70) |  |  | $ | (0.55) |
Weighted-Average Shares of Class A Common Stock Outstanding: |  |  |  |  |  |  |  |
Basic and Diluted |  | 95,197,500 |  |  | 74,836,884 |  |  | 88,137,939 |  |  | 72,235,763 |

The accompanying notes are an integral part of these financial statements.
2

NuScale Power Corporation
Condensed Consolidated Statements of Changes in Stockholders’ Equity

(in thousands) |  | Common Stock |  |  |  |  |  |  |  |
| Class A |  | Class B |  | Additional Paid-in Capital |  | Accumulated Deficit |  | Noncontrolling Interests |  | Total Stockholders’ Equity
| Shares |  | Amount |  | Shares |  | Amount |  |  |  |
Balances at June 30, 2024 (Unaudited) |  | 92,486 |  |  | $ | 9 |  |  | 154,465 |  |  | $ | 15 |  |  | $ | 420,948 |  |  | $ | (284,643) |  |  | $ | (43,018) |  |  | $ | 93,311 |
Equity-based compensation expense |  | — |  |  | — |  |  | — |  |  | — |  |  | 3,946 |  |  | — |  |  | — |  |  | 3,946 |
Exercise of common share options and warrants and vested RSUs |  | 2,244 |  |  | — |  |  | — |  |  | — |  |  | 7,221 |  |  | — |  |  | — |  |  | 7,221 |
Issuance of Class A common stock |  | 2,965 |  |  | 1 |  |  | — |  |  | — |  |  | 31,200 |  |  | — |  |  | — |  |  | 31,201 |
Exchange of combined interests for Class A common stock |  | 199 |  |  | — |  |  | (199) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Rebalancing of ownership percentage for exchange of combined interest into Class A shares |  | — |  |  | — |  |  | — |  |  | — |  |  | (1,169) |  |  | — |  |  | 1,169 |  |  | — |
Net loss |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (17,459) |  |  | (28,095) |  |  | (45,554) |
Balances at September 30, 2024 (Unaudited) |  | 97,894 |  |  | $ | 10 |  |  | 154,266 |  |  | $ | 15 |  |  | $ | 462,146 |  |  | $ | (302,102) |  |  | $ | (69,944) |  |  | $ | 90,125 |

(in thousands) |  | Common Stock |  |  |  |  |  |  |  |
| Class A |  | Class B |  | Additional Paid-in Capital |  | Accumulated Deficit |  | Noncontrolling Interests |  | Total Stockholders’ Equity
| Shares |  | Amount |  | Shares |  | Amount |  |  |  |
Balances at December 31, 2023 |  | 76,895 |  |  | $ | 8 |  |  | 154,477 |  |  | $ | 15 |  |  | $ | 333,888 |  |  | $ | (240,454) |  |  | $ | 35,881 |  |  | $ | 129,338 |
Equity-based compensation expense |  |  |  | — |  |  | — |  |  | — |  |  | 10,442 |  |  |  |  |  |  | 10,442 |
Exercise of common share options and warrants and vested RSUs |  | 5,126 |  |  | — |  |  | — |  |  | — |  |  | 14,575 |  |  |  |  |  |  | 14,575 |
Issuance of Class A common stock |  | 15,662 |  |  | 2 |  |  | — |  |  | — |  |  | 103,840 |  |  |  |  |  |  | 103,842 |
Exchange of combined interests for Class A common stock |  | 211 |  |  | — |  |  | (211) |  |  | — |  |  |  |  |  |  |  |  | — |
Rebalancing of ownership percentage for exchange of combined interest into Class A shares |  | — |  |  | — |  |  | — |  |  | — |  |  | (599) |  |  |  |  | 599 |  |  | — |
Net loss |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (61,648) |  |  | (106,424) |  |  | (168,072) |
Balances at September 30, 2024 (Unaudited) |  | 97,894 |  |  | $ | 10 |  |  | 154,266 |  |  | $ | 15 |  |  | $ | 462,146 |  |  | $ | (302,102) |  |  | $ | (69,944) |  |  | $ | 90,125 |

3

NuScale Power Corporation
Condensed Consolidated Statements of Changes in Stockholders’ Equity

(in thousands) |  | Common Stock |  |  |  |  |  |  |  |
| Class A |  | Class B |  | Additional Paid-in Capital |  | Accumulated Deficit |  | Noncontrolling Interests |  | Total Stockholders’ Equity
| Shares |  | Amount |  | Shares |  | Amount |  |  |  |
Balances at June 30, 2023 (Unaudited) |  | 74,045 |  |  | $ | 7 |  |  | 154,720 |  |  | $ | 16 |  |  | $ | 312,618 |  |  | $ | (202,577) |  |  | $ | 114,140 |  |  | $ | 224,204 |
Equity-based compensation expense |  | — |  |  | — |  |  | — |  |  | — |  |  | 4,009 |  |  | — |  |  | — |  |  | 4,009 |
Exercise of common share options, warrants and vested RSUs |  | 823 |  |  | — |  |  | — |  |  | — |  |  | 7,867 |  |  | — |  |  | — |  |  | 7,867 |
Issuance of Class A common stock |  | 1,386 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | $ | — |
Exchange of combined interests for Class A common stock |  | 163 |  |  | 1 |  |  | (163) |  |  | (1) |  |  | 1,895 |  |  | — |  |  | — |  |  | 1,895 |
Rebalancing of ownership percentage for exchange of combined interest into Class A shares |  | — |  |  | — |  |  | — |  |  | — |  |  | 1,204 |  |  | — |  |  | (1,204) |  |  | — |
Net loss |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (19,122) |  |  | (39,206) |  |  | (58,328) |
Balances at September 30, 2023 (Unaudited) |  | 76,417 |  |  | $ | 8 |  |  | 154,557 |  |  | $ | 15 |  |  | $ | 327,593 |  |  | $ | (221,699) |  |  | $ | 73,730 |  |  | $ | 179,647 |

(in thousands) |  | Common Stock |  |  |  |  |  |  |  |
| Class A |  | Class B |  | Additional Paid-in Capital |  | Accumulated Deficit |  | Noncontrolling Interests |  | Total Stockholders’ Equity
| Shares |  | Amount |  | Shares |  | Amount |  |  |  |
Balances at December 31, 2022 |  | 69,353 |  |  | $ | 7 |  |  | 157,091 |  |  | $ | 16 |  |  | $ | 296,748 |  |  | $ | (182,092) |  |  | $ | 162,408 |  |  | $ | 277,087 |
Equity-based compensation expense |  |  |  | — |  |  | — |  |  | — |  |  | 12,099 |  |  | — |  |  | — |  |  | 12,099 |
Exercise of common share options, warrants and vested RSUs |  | 3,144 |  |  | — |  |  | — |  |  | — |  |  | 7,867 |  |  | — |  |  | — |  |  | 7,867 |
Issuance of Class A common stock |  | 1,386 |  |  | — |  |  | — |  |  | — |  |  | 6,266 |  |  | — |  |  | — |  |  | $ | 6,266 |
Exchange of combined interests for Class A common stock |  | 2,534 |  |  | 1 |  |  | (2,534) |  |  | (1) |  |  | — |  |  | — |  |  | — |  |  | — |
Rebalancing of ownership percentage for exchange of combined interest into Class A shares |  | — |  |  | — |  |  | — |  |  | — |  |  | 4,613 |  |  | — |  |  | (4,613) |  |  | — |
Net loss |  |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (39,607) |  |  | (84,065) |  |  | (123,672) |
Balances at September 30, 2023 (Unaudited) |  | 76,417 |  |  | $ | 8 |  |  | 154,557 |  |  | $ | 15 |  |  | $ | 327,593 |  |  | $ | (221,699) |  |  | $ | 73,730 |  |  | $ | 179,647 |

The accompanying notes are an integral part of these financial statements.
4

NuScale Power Corporation
Condensed Consolidated Statements of Cash Flows
(Unaudited)

(in thousands) |  |
| Nine Months Ended September 30,
| 2024 |  | 2023
OPERATING CASH FLOW |  |  |  |
Net Loss |  | $ | (168,072) |  |  | $ | (123,672) |
Adjustments to reconcile net loss to operating cash flow: |  |  |  |
Depreciation |  | 1,286 |  |  | 1,813 |
Amortization of intangibles |  | 133 |  |  | 133 |
Equity-based compensation expense |  | 10,442 |  |  | 12,099 |
Provision for credit losses |  | 57 |  |  | — |
Impairment of intangible asset |  | 71 |  |  | — |
Gain on insurance proceeds received for damage to property, plant and equipment |  | (122) |  |  | — |
Change in fair value of warrant liabilities |  | 52,969 |  |  | (17,167) |
Net noncash change in right of use assets and lease liabilities |  | (274) |  |  | (230) |
Changes in assets and liabilities: |  |  |  |
Prepaid expenses and other assets |  | 8,474 |  |  | (18,377) |
Accounts and other receivables |  | 2,157 |  |  | (8,991) |
Long-term contract work in process |  | (5,248) |  |  | (30,765) |
Long-lead material liability |  | 741 |  |  | 34,500 |
Accounts payable and accrued expenses |  | (2,044) |  |  | 8,830 |
Nonrefundable customer deposit |  | 20,000 |  |  | — |
Lease liability |  | (1,202) |  |  | (1,290) |
Deferred revenue |  | (820) |  |  | 32,525 |
Accrued compensation |  | (797) |  |  | 550 |
Net Cash Used in Operating Activities |  | (82,249) |  |  | (110,042) |
INVESTING CASH FLOW |  |  |  |
Sale of short-term investments |  | — |  |  | 50,000 |
Purchase of short-term investments |  | (45,000) |  |  | — |
Insurance proceeds received for damage to property, plant and equipment |  | 195 |  |  | — |
Purchases of property, plant and equipment |  | — |  |  | (1,674) |
Net Cash (Used) Provided by Investing Activities |  | (44,805) |  |  | 48,326 |
FINANCING CASH FLOW |  |  |  |
Proceeds from the issuance of common stock, net of issuance fees |  | 103,842 |  |  | 7,867 |
Proceeds from exercise of warrants and common share options |  | 14,575 |  |  | 6,266 |
Net Cash Provided by Financing Activities |  | 118,417 |  |  | 14,133 |
Net Change in Cash, Cash Equivalents and Restricted Cash |  | (8,637) |  |  | (47,583) |
Cash, cash equivalents and restricted cash: |  |  |  |
Beginning of period |  | 125,365 |  |  | 244,217 |
End of period |  | $ | 116,728 |  |  | $ | 196,634 |
Supplemental disclosures of cash flow information: |  |  |  |
Foreign income taxes paid |  | $ | 3,212 |  |  | $ | — |

The accompanying notes are an integral part of these financial statements.
5

NuScale Power Corporation
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands, except shares and per share amounts)
1.Nature of Business
Organization
NuScale Corp (“NuScale”, the “Company”, “us”, “we” or “our”) is incorporated under the laws of the state of Delaware. The Company is the primary beneficiary of NuScale LLC, a variable interest entity, and all activity of NuScale LLC and the Company are consolidated herein. NuScale LLC is a limited liability company organized in the State of Oregon in 2011. As at September 30, 2024, NuScale was majority owned by Fluor Enterprises, Inc., a subsidiary of Fluor Corporation; however, subsequent to September 30, 2024, Fluor’s ownership fell below 50%.
Operations
The Company is commercializing a modular, scalable 77 megawatt (gross) electric Light Water Reactor nuclear power plant using exclusive rights to a nuclear power plant design obtained from Oregon State University (“OSU”). The following represents key milestones in the development of this technology:
•December 2016: DCA completed
•January 2017: DCA submitted to the NRC
•March 2017: DCA accepted for review by the NRC
•August 2020: NRC issued the Final Safety Evaluation Report ("FSER")
•July 2023: SDA Application and associated licensing topical reports accepted for formal review by the NRC
The FSER represents the NRC’s completion of its technical review and approval of the NuScale SMR design. With this final phase of NuScale’s DCA now complete, customers may proceed with plans to develop NuScale power plants with the understanding that the NRC has approved the safety aspects of the NuScale design. Based on the NRC’s published schedule for SDA Application review, we expect the NRC will complete its review and SDA approval to be received by July 31, 2025.
The majority of the Company’s operations and long-lived assets were attributable to operations in the United States other than the long-lead material work in process being manufactured in South Korea during the 2023 and 2024 fiscal years.
On January 5, 2024, NuScale announced a plan to reduce the Company’s workforce by 154 full time employees, or 28%, in order to continue our transition from a R&D-based company to a commercial company. This resulted in a one-time charge of $3,236 during the nine months ended September 30, 2024, and is included in Other expenses on the condensed consolidated income statement.
As a result of the cost optimization plans implemented by management, the utilization of our ATM Program and execution of customer contracts, we believe we will have sufficient funds available to cover required R&D activities and operating cash needs for the next twelve months.
2.Summary of Significant Accounting Policies
Basis of Presentation
The Company’s unaudited condensed consolidated financial statements and related notes do not include notes and certain financial information normally presented annually under GAAP, and therefore should be read in conjunction with our 2023 Form 10-K. Accounting measures at interim dates inherently involve greater reliance on estimates than at year-end. Although such estimates are based on management’s most recent assessment of the underlying facts and circumstances utilizing the most current information available, our reported results of operations may not necessarily be indicative of results that we expect for the full year.
These financial statements are unaudited. In management’s opinion, they contain all adjustments of a normal recurring nature which are necessary to present fairly our financial position and our operating results as of and for the interim periods presented.
6

NuScale Power Corporation
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands, except shares and per share amounts)
Principles of Consolidation
As part of the Transaction, NuScale Corp has been determined to be the primary beneficiary of NuScale LLC, a variable interest entity (“VIE”). As the sole managing member of NuScale LLC, NuScale Corp has both the power to direct the activities, and direct ownership to share in the revenues and expenses of NuScale LLC. As such, all the activity of NuScale LLC has been consolidated in the accompanying condensed consolidated financial statements. All assets and liabilities included in the balance sheet are that of NuScale LLC, other than the NuScale Corp Warrants and certain prepaid assets. All significant intercompany transactions have been eliminated upon consolidation.
Changes in Presentation
For the nine months ended September 30, 2023, amounts totaling $1,855 were reclassified out of Other expenses and into R&D expenses to conform to the current year presentation.
Cash, Cash Equivalents and Restricted Cash
Cash equivalents represent short-term, highly liquid investments, which are readily convertible to cash and have maturities of three months or less at time of purchase, while cash equivalents with an initial maturity of between three and twelve months at time of purchase are considered short-term investments. The Company’s cash equivalents consist of certificates of deposit, are classified as held-to-maturity, and the estimated fair value of the investment approximates its amortized cost.
Cash in the amount of $5,100 is restricted as collateral for the letter of credit associated with the Release Agreement with CFPP LLC at September 30, 2024 and December 31, 2023, and is identified as Restricted cash in the condensed consolidated balance sheet. The restricted cash balance plus cash and cash equivalents on the condensed consolidated balance sheet equals cash, cash equivalents and restricted cash, as reflected in the condensed consolidated statements of cash flows.
Sales and Marketing Agreements
The Company has entered into sales and marketing agreements pursuant to which it prepaid certain expenses to the counterparty. As of September 30, 2024 and December 31, 2023, the balance of $3,750 and $15,000, respectively, is included in Prepaid expenses on the accompanying condensed consolidated balance sheet and will be amortized monthly on a straight-line basis through December 31, 2024.
Warrant Liability
The Company accounts for the Warrants in accordance with the guidance contained in Accounting Standards Codification (“ASC”) 815, “Derivatives and Hedging”, under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjusts the Warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s condensed consolidated statements of operations. The fair value of the Public and Private Placement Warrants at December 31, 2023 has been estimated using the Public Warrants’ quoted market price, while all Warrants are Public Warrants as of September 30, 2024.
Revenue Recognition
As we continue to transition from a R&D company toward the commercialization of our SMR, we continue to expand our array of products and services. During the third fiscal quarter of 2024, the Company entered into a revenue generating agreement with a customer, structured as a fixed price contract with variable consideration. Under this fixed price contract, all amounts currently collected are deferred and included in Customer deposit on the condensed consolidated balance sheet, with revenue to be recognized as performance obligations are achieved.
7

NuScale Power Corporation
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands, except shares and per share amounts)
Subsequent to September 30, 2024, the Company executed a revenue generating agreement with Fluor, whereby NuScale will provide engineering and design services in support of Phase 2 Front-End Engineering and Design for a VOYGR TM-6 Nuclear Power Generation project.
Sponsored Cost Share
As our commercialization activities advance, we have continued to enter into cost share agreements with various entities, including both governmental and private, under which the Company is reimbursed for specific R&D activities. As of September 30, 2024, these entities include the United States Department of State and United States Trade and Development Agency (combined as “USG”), RoPower, DOE and CFPP LLC.
Beginning in 2021, the Company partnered with USG to develop SMRs in foreign markets. Under USG’s technical assistance grant programs, we receive cost share commitments to support licensing work in these foreign markets, one of which is additionally supported by RoPower. During the three months ended September 30, 2024 and 2023, USG cost share totaled $641 and $10,521, respectively, while during the nine months ended September 30, 2024 and 2023, USG cost share totaled $5,833 and $20,080, respectively.
Since 2014, DOE has provided critical funding to the Company through a series of cooperative agreements that support ongoing commercialization activities. During the nine months ended September 30, 2024, DOE cost share totaled $336, while during the three and nine months ended September 30, 2023, DOE cost share totaled $9,171 and $28,718, respectively.
Finally, we receive subrecipient cost share from CFPP LLC under a contract between the DOE and UAMPS for R&D performed with the goal of developing our first SMR. Under this agreement we received cost share of $19 and $1,082 during the three months ended September 30, 2024 and 2023, respectively, while for the nine months ended September 30, 2024 and 2023, the Company received cost share of $335 and $6,186, respectively.
Recent Accounting Pronouncements
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740) – Improvements to Income Tax Disclosures (ASU 2023-09). ASU 2023-09 requires that an entity, on an annual basis, disclose additional income tax information, primarily related to the rate reconciliation and income taxes paid. The amendment in the ASU is intended to enhance the transparency and decision usefulness of income tax disclosures. The ASU’s amendments are effective for annual periods beginning after December 15, 2024. The Company is currently evaluating the impact that adoption of ASU 2023-09 will have on our condensed consolidated financial statements.
In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280) – Improvements to Reportable Segment Disclosures. ASU 2023-07 requires annual and interim disclosures that are expected to improve reportable segment disclosures, primarily through enhanced disclosures about significant segment expenses. The provisions of ASU 2023-07 are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating ASU 2023-07 to determine its impact on the Company’s disclosures, however, the Company does not expect ASU 2023-07 to have a material impact.
3.Noncontrolling Interests and Loss Per Share
Noncontrolling Interests
Following the Transaction, holders of Class A common stock own direct controlling interests in the results of the combined entity, while the Legacy NuScale Equityholders own an economic interest in NuScale LLC, shown as noncontrolling interests (“NCI”) in equity in NuScale Corp’s condensed consolidated financial statements. The indirect economic interests are held by Legacy NuScale Equityholders in the form of NuScale LLC Class B Units. The
8

NuScale Power Corporation
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands, except shares and per share amounts)
following table summarizes the economic interests of NuScale Corp between the holders of Class A common stock and indirect economic interests held by NuScale LLC Class B unitholders.

|  | As of and for the Three Months Ended September 30, |  | As of and for the Nine Months Ended September 30,
Noncontrolling Interests |  | 2024 |  | 2023 |  | 2024 |  | 2023
NuScale Corp Class A common stock |  |  |  |  |  |  |  |
Beginning of period |  | 92,486,358 |  | 74,045,206 |  | 76,895,166 |  | 69,353,019
Exchange of combined interests for Class A common stock |  | 198,335 |  | 163,497 |  | 210,632 |  | 2,534,302
Issuance of Class A common stock |  | 2,964,586 |  | 822,332 |  | 15,661,580 |  | 3,143,714
Exercise of options, warrants and vested RSUs |  | 2,244,605 |  | 1,385,623 |  | 5,126,506 |  | 1,385,623
End of period |  | 97,893,884 |  | 76,416,658 |  | 97,893,884 |  | 76,416,658
NuScale LLC Class B Units (NCI) |  |  |  |  |  |  |  |
Beginning of period |  | 154,464,735 |  | 154,720,015 |  | 154,477,032 |  | 157,090,820
Exchange of combined interests for Class A common stock |  | (198,335) |  | (163,497) |  | (210,632) |  | (2,534,302)
End of period |  | 154,266,400 |  | 154,556,518 |  | 154,266,400 |  | 154,556,518
Total |  |  |  |  |  |  |  |
Beginning of period |  | 246,951,093 |  | 228,765,221 |  | 231,372,198 |  | 226,443,839
Issuance of Class A common stock |  | 2,964,586 |  | 822,332 |  | 15,661,580 |  | 3,143,714
Exercise of options, warrants and vested RSUs |  | 2,244,605 |  | 1,385,623 |  | 5,126,506 |  | 1,385,623
End of period |  | 252,160,284 |  | 230,973,176 |  | 252,160,284 |  | 230,973,176
Ownership Percentage |  |  |  |  |  |  |  |
NuScale Corp Class A common stock |  |  |  |  |  |  |  |
Beginning of period |  | 37.5 | % |  | 32.4 | % |  | 33.2 | % |  | 30.6 | %
End of period |  | 38.8 | % |  | 33.1 | % |  | 38.8 | % |  | 33.1 | %
NuScale LLC Class B Units (NCI) |  |  |  |  |  |  |  |
Beginning of period |  | 62.5 | % |  | 67.6 | % |  | 66.8 | % |  | 69.4 | %
End of period |  | 61.2 | % |  | 66.9 | % |  | 61.2 | % |  | 66.9 | %

The NCI may decrease according to the number of shares of Class B common stock and NuScale LLC Class B units that are exchanged for shares of Class A common stock or, in certain circumstances including at the election of NuScale Corp, cash in an amount equal to the fair value of Class A common stock received in a contemporaneous equity issuance. After each exchange, NuScale LLC equity attributable to NuScale Corp is rebalanced to reflect the change in ownership percentage, which is calculated above based on Class B units and Class A shares, as a percentage of Combined interests.
Loss Per Share
9

NuScale Power Corporation
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands, except shares and per share amounts)
Basic loss per share is based on the average number of shares of Class A common stock outstanding during the period. Diluted loss per share is based on the average number of shares of Class A common stock used for the basic earnings per share calculation, adjusted for the dilutive effect of RSUs, Stock Options and Warrants using the “treasury stock” method and for all other interests that convert into potential shares of Class A common stock, if any, using the “if converted” method. Net loss attributable to Class A common stockholders for diluted loss per share is adjusted for the Company’s share of NuScale LLC’s net loss, net of NuScale Corp taxes, after giving effect to all other interests that convert into potential shares of Class A common stock, to the extent it is dilutive. In addition, net loss attributable to Class A common stockholders for diluted loss per share is adjusted for the after-tax impact of changes to the fair value of derivative liabilities, to the extent the Company’s Warrants are dilutive.
The following table sets forth the computation of basic and diluted net loss per share of Class A common stock. Class B common stock represents a right to cast one vote per share at the NuScale Corp level, and carries no economic rights, including rights to dividends or distributions upon liquidation, and as a result, is not considered a participating security for basic and diluted loss per share. As such, basic and diluted loss per share of Class B common stock has not been presented.

|  | As of and for the Three Months Ended September 30, |  | As of and for the Nine Months Ended September 30,
(in thousands, except share and per share amounts) |  | 2024 |  | 2023 |  | 2024 |  | 2023
Net loss attributable to Class A common stockholders |  | $ | (17,459) |  |  | $ | (19,122) |  |  | $ | (61,648) |  |  | $ | (39,607) |
Weighted-average shares for basic and diluted loss per share |  | 95,197,500 |  |  | 74,836,884 |  |  | 88,137,939 |  |  | 72,235,763 |
Basic and Diluted loss per share of Class A common stock |  | $ | (0.18) |  |  | $ | (0.26) |  |  | $ | (0.70) |  |  | $ | (0.55) |
Anti-dilutive securities excluded from shares outstanding: |  |  |  |  |  |  |  |
Shares of Class B common stock |  | 154,266,400 |  |  | 154,556,518 |  |  | 154,266,400 |  |  | 154,556,518 |
Stock options |  | 7,684,894 |  |  | 9,606,510 |  |  | 7,684,894 |  |  | 9,606,510 |
Warrants |  | 18,455,747 |  |  | 18,458,701 |  |  | 18,455,747 |  |  | 18,458,701 |
Time-based RSUs |  | 5,296,625 |  |  | 3,335,535 |  |  | 5,296,625 |  |  | 3,335,535 |
Total |  | 185,703,666 |  |  | 185,957,264 |  |  | 185,703,666 |  |  | 185,957,264 |

During the three months ended September 30, 2024, the ATM Program generated gross proceeds of $32,001 and net proceeds of $31,201, while for the nine months ended September 30, 2024 the ATM Program generated gross and net proceeds of $106,503 and $103,840, respectively. During the three and nine months ended September 30, 2023, the ATM Program generated gross and net proceeds of $8,337 and $7,867, respectively. As of September 30, 2024, we have 2,601,042 shares of Class A common stock authorized and available under the ATM Program at an aggregate sales price of up to $33,141.
During the three and nine months ended September 30, 2024, the Company issued and sold shares of Class A common stock in the amount of 2,964,586 and 15,661,580, respectively, at a weighted average price of $10.79 and $6.80 per share, respectively, while during the three and nine months ended September 30, 2023, NuScale issued and sold 1,385,623 shares of Class A common stock, with a weighted average price of $6.02.
Subsequent to September 30, 2024, the Company issued and sold 2,601,042 shares of Class A common stock under the ATM Program for the gross and net proceeds of $32,451 and $31,639, respectively.
4.Warrant Liabilities
Under the Company’s Warrant Agreement, when Private Placement Warrants are transferred by Spring Valley Acquisition Sponsor, LLC, a Delaware limited liability company (the “Sponsor”), to persons who are not “Permitted
10

NuScale Power Corporation
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands, except shares and per share amounts)
Transferees” (as defined in the Warrant Agreement) of the Sponsor, they cease to be Private Placement Warrants and become Public Warrants under the Warrant Agreement. The Company has been informed by the Sponsor that the Private Placement Warrants were transferred in accordance with the Warrant Agreement to persons who are not Permitted Transferees. Consequently, the previously described Private Placement Warrants are now Public Warrants under the Warrant Agreement, resulting in all 18,455,723 warrants identified as Public Warrants in Note 5, Fair Value Measurement, as of September 30, 2024. During the three and nine months ended September 30, 2024, 2,954 warrants were exercised for Class A common shares and $34 cash.
Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Warrants. The Warrants are currently exercisable and will expire on May 2, 2027 (five years from the date of the Transaction) or earlier upon redemption or liquidation.
Redemption of Warrants when the price per share of Class A common stock equals or exceeds $18.00. The Company may redeem the outstanding Warrants:
•in whole and not in part;
•at a price of $0.01 per Warrant;
•upon a minimum of 30 days prior written notice of redemption to each Warrant holder; and
•if, and only if, the closing price of the Class A common stock equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending three trading days before the Company sends the notice of redemption to the Warrant holders.
The Company will not redeem the Warrants as described above unless a registration statement under the Securities Act covering the issuance of the Class A common stock issuable upon exercise of the Warrants is then effective and a current prospectus relating to those shares of Class A common stock is available throughout the 30-day redemption period. If and when the Warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.
Redemption of Warrants when the price per share of Class A common stock equals or exceeds $10.00. The Company may redeem the outstanding Warrants:
•in whole and not in part;
•at $0.10 per Warrant upon a minimum of 30 days prior written notice of redemption provided that holders will be able to exercise their Warrants on a cashless basis prior to redemption and receive that number of shares determined as set forth in the Warrant Agreement, based on the redemption date and the fair market value of the Class A common stock, subject to certain exceptions; and
•if, and only if, the closing price of the Class A common stock equals or exceeds $10.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant based on anti-dilution adjustments set forth in the Warrant Agreement) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption to the Warrant holders.
The Warrants may be exercised for cash (or on a cashless basis as described above in “-Redemption of Warrants when the price per share of Class A common stock equals or exceeds $10.00”) at any time after notice of redemption shall have been given by the Company and prior to the redemption date.
For a complete description of the Warrants, please see the Warrant Agreement, which is Exhibit 4.2 to the 2023 Form 10-K, and the section entitled “Warrants” in the “Description of Registrant’s Securities,” which is Exhibit 4.3 to the 2023 Form 10-K.
5.Fair Value Measurement
The Company measures certain financial assets and liabilities at fair value. Fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the Company uses a three-level hierarchy, which prioritizes fair value
11

NuScale Power Corporation
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands, except shares and per share amounts)
measurements based on the types of inputs used for the various valuation techniques (market approach, income approach and cost approach).
The levels of hierarchy are described below:
Level 1 Quoted prices in active markets for identical instruments;
Level 2 Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and
Level 3 Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability. Financial assets and liabilities are classified in their entirety based on the most stringent level of input that is significant to the fair value measurement.
The carrying amount of certain financial instruments, including deposits, accounts payable and accrued expenses, approximates fair value due to their short maturities.
Our Warrants are accounted for as liabilities pursuant to ASC 815-40 and are measured at fair value as of each reporting period. Changes in fair value of the Warrants are recorded in the statement of operations each period. As discussed in Note 4, Warrant Liabilities, because the Private Placement Warrants are no longer held by the Sponsor or a “Permitted Transferee” of the Sponsor, the Private Placement Warrants are Public Warrants under the Warrant Agreement. In light of these circumstances, we have classified both the Private Placement Warrants and the Public Warrants as Level 1 as of September 30, 2024.
The following tables represents the Company’s financial liabilities measured at fair value on a recurring basis:

(in thousands) |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
Warrant Liabilities: |  |  |  |  |  |  |  |
Public Warrants |  | $ | 58,681 |  |  | $ | — |  |  | $ | — |  |  | $ | 58,681 |
Total Warrant Liabilities as of September 30, 2024 |  | $ | 58,681 |  |  | $ | — |  |  | $ | — |  |  | $ | 58,681 |

(in thousands) |  | Level 1 |  | Level 2 |  | Level 3 |  | Total
Warrant Liabilities: |  |  |  |  |  |  |  |
Public Warrants |  | $ | 2,963 |  |  | $ | — |  |  | $ | — |  |  | $ | 2,963 |
Private Placement Warrants |  | — |  |  | 2,759 |  |  | — |  |  | 2,759 |
Total Warrant Liabilities as of December 31, 2023 |  | $ | 2,963 |  |  | $ | 2,759 |  |  | $ | — |  |  | $ | 5,722 |

6.Accounts and Other Receivables
Accounts and other receivables, net include reimbursement requests outstanding from the cost share awards, interest receivable and commercial accounts receivable. The cost share reimbursement requests are recognized as eligible costs are incurred. Reimbursement under the awards is recognized as award funds are obligated, and are included in Sponsored cost share in the condensed consolidated statement of operations. Interest receivable of $740 and $318 was outstanding at September 30, 2024 and December 31, 2023, respectively.
12

NuScale Power Corporation
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands, except shares and per share amounts)
The majority of our receivables are either due from the U.S. federal government or have to do with a federal project. For these reasons, the majority of receivables are deemed to be fully collectible and only an immaterial allowance has been recorded.
7.Property, Plant and Equipment
Property, plant and equipment consisted of the following:

(in thousands) |  | September 30, 2024 |  | December 31, 2023
Furniture and fixtures |  | $ | 27 |  |  | $ | 27 |
Office and computer equipment |  | 7,222 |  |  | 7,274 |
Software |  | 13,898 |  |  | 14,102 |
Operations equipment |  | 1,165 |  |  | 1,165 |
Leasehold improvements |  | 2,189 |  |  | 2,293 |
|  | 24,501 |  |  | 24,861 |
Less: Accumulated depreciation |  | (21,745) |  |  | (20,745) |
Net property, plant and equipment |  | $ | 2,756 |  |  | $ | 4,116 |

Depreciation of property, plant and equipment for the three months ended September 30, 2024 and 2023 was $394 and $641, respectively. Of these amounts, $73 and $321 is included in G&A expenses and Other expense, respectively, for the 2024 fiscal year and $120 and $521, respectively, for the 2023 fiscal year.
During the nine months ended September 30, 2024 depreciation in the amount of $247 and $1,039 is included in G&A expenses and Other expense, respectively, and $397 and $1,416, respectively, for the same period in the prior fiscal year.
8.Long-Lead Material Work In Process and Liability
During the first quarter of 2023, we entered into the LLM Agreement with CFPP LLC. Related to this contract, the Company has subcontracted for the purchase of certain long-lead materials (“LLM”) in the amount of $55,700, that were to be used in fabrication of the NPMs as part of the DCRA with CFPP LLC. However, on November 7, 2023, NuScale and CFPP LLC entered into the Release Agreement whereby the DCRA and LLM Agreement would be suspended, while wind down procedures and the ultimate disposition of the long-lead materials would be negotiated between the Company, CFPP LLC and DOE. As part of the Release Agreement, NuScale was required to pay $49,769 to CFPP LLC and provide a letter of credit in the amount of $5,000 for demobilization and wind down costs. This letter of credit is collateralized by $5,100 and included in the accompanying condensed consolidated balance sheet as Restricted cash as of September 30, 2024 and December 31, 2023.
Upon final settlement of the LLM Agreement, and once DOE is compensated for its investment in the LLM (stemming from DOE’s funding under its cost share agreement with CFPP LLC), NuScale will obtain all rights and obligations of the LLM. As a result of DOE’s investment in the LLM, as of September 30, 2024 and December 31, 2023, NuScale has included a Long-lead material liability on the accompanying condensed consolidated balance sheet in the amount of $33,064 and $32,323, respectively, for the estimated cost to gain 100% of the LLM, once completed. The LLM represents in-process inventory recorded at cost and is identified as Long-lead material work in process on the condensed consolidated balance sheet in the amount of $41,609 and $36,361 as of September 30, 2024 and December 31, 2023, respectively.
9.Customer Deposit
As previously noted, in the third quarter, NuScale entered into a fixed price contract with variable consideration. At that time the Company was paid an upfront fee that is nonrefundable but cannot be recognized as revenue under GAAP until the performance obligations have been achieved, which we anticipate occurring during the fourth quarter of 2024. At December 31, 2023, there were no customer deposits included in our consolidated balance sheet.
13

NuScale Power Corporation
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands, except shares and per share amounts)
10.Noncurrent Accounts Payable and Accrued Expenses
During May 2024, a contract with one of NuScale’s LLM manufacturing vendors was renegotiated as a result of the Release Agreement with CFPP LLC. This amendment resulted in new production milestones, with interest-free payments expected in December 2025. Should the payments be deferred to a later date, interest will begin accruing on January 1, 2026. As of September 30, 2024, the balance totals $23,212 and is included in Noncurrent accounts payable and accrued expenses in the accompanying condensed consolidated balance sheet.
11.Employee Benefits
The Company sponsors a defined contribution 401(k) Plan with contributions to be made at the sole discretion of the management. Under the provisions of the 401(k) Plan, the Company matches the employees’ contributions for the first 3% of compensation and matches 50% of the employees’ contributions for the next 2% of compensation. The expense recorded for the 401(k) Plan was $396 and $578 for the three months ended September 30, 2024 and 2023, respectively, and $1,535 and $2,020 for the nine months ended September 30, 2024 and 2023, respectively.
12.Income Taxes
NuScale LLC was historically and remains a partnership for U.S. federal income tax purposes with each partner being separately taxed on its share of taxable income or loss. NuScale Corp is subject to U.S. federal income taxes, in addition to state and local income taxes, with respect to its distributive share of any net taxable income or loss and any related tax credits of NuScale LLC.
The effective tax rate was 0% for the three and nine months ended September 30, 2024. The effective income tax rate for the three and nine months ended September 30, 2024 differed significantly from the statutory rates, primarily due to the losses allocated to the NCI and the recognition of a valuation allowance as a result of the Company’s new tax structure following the Transaction.
During the three and nine months ended September 30, 2024, the Company incurred a minimal amount of foreign income tax expense, while incurring no such expense during the same periods in the prior year. However, during the third quarter, NuScale received a customer deposit from a Romanian entity subject to Romanian withholding tax in the amount of $3,200. This amount is included in Prepaid expenses in the condensed consolidated balance sheet at September 30, 2024 and will be expensed as the revenue is recognized. No such amount was prepaid as of December 31, 2023.
The Company has assessed the realizability of the net deferred tax assets and in that analysis has considered the relevant positive and negative evidence available to determine whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The Company has recorded a full valuation allowance against the deferred tax assets at NuScale Corp as of September 30, 2024, which will be maintained until there is sufficient evidence to support the reversal of all or some portion of these allowances.
The Company’s income tax filings will be subject to audit by various taxing jurisdictions. The Company will monitor the status of U.S. federal, state and local income tax returns that may be subject to audit in future periods. No U.S. federal, state and local income tax returns are currently under examination by the respective taxing authorities.
13.Equity-Based Compensation
The total compensation expense recognized for common share options and time-based RSU awards during the three months ended September 30, 2024 and 2023 was $3,946 and $4,009, respectively, and $10,442 and $12,099 for the nine months ended September 30, 2024 and 2023, respectively. For the three months ended September 30, 2024, equity-based compensation of $2,017 was included in G&A expense and $1,929 was included in Other expense, compared to $1,496 and $2,513, respectively, over the same period in the prior year. For the nine months ended September 30, 2024, equity based compensation of $5,445 was included in G&A expense and $4,997 included in Other expense compared to $4,857 and $7,242, respectively, over the same period in the prior year.
14

NuScale Power Corporation
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands, except shares and per share amounts)
Stock Options
During the nine months ended September 30, 2024, the Board approved 2,909,375 employee share option awards, with an aggregate fair value of $6,401, that vest one-third annually starting in February 2025 for a period of three years.
The Company measures the fair value of each share option grant at the date of grant using a Black-Scholes option pricing model.
Time-based RSUs
During the nine months ended September 30, 2024, the Company granted employees 4,598,635 RSUs with an aggregate value of $14,716. The RSUs vest one-third annually starting in February 2025. During the three and nine months ended September 30, 2024, RSUs of 179,053 and 1,097,292, respectively, vested with Class A common shares issued.
14.Related Party Transactions
From time to time, the Company enters into strategic agreements with Fluor, whereby Fluor or the Company perform services for one another. For the three months ended September 30, 2024 and 2023, we incurred expenses of $229 and $10,763, respectively, while for the nine months ended September 30, 2024 and 2023, we incurred expenses of $767 and $27,968, respectively. As of September 30, 2024 and December 31, 2023, the Company owed Fluor, as Accounts payable and accrued expenses on the condensed consolidated balance sheet, amounts totaling $802 and $4,080, respectively. For the three months ended September 30, 2024 and 2023, we earned revenue of $47 and $5,302, respectively, and for the nine months ended September 30, 2024 and 2023, we earned $570 and $14,072, respectively. At December 31, 2023, Fluor owed us $2,642, with no such amount outstanding as of September 30, 2024, amounts which are included in Accounts and other receivables, net on the condensed consolidated balance sheet.
For the three months ended September 30, 2024 and 2023, Fluor accounted for 10% and 76%, respectively, of total revenue, while for the nine months ended September 30, 2024 and 2023, they accounted for 20% and 77%, respectively.
15.Commitments and Contingencies
In the regular course of business, the Company is involved in various legal proceedings and claims incidental to the normal course of business. Other than as disclosed immediately below, the Company does not believe that any legal claims are material to the Company. Management does not believe that resolution of any of these matters will materially affect the Company’s financial position or results of operations.
On September 19, 2022, thirteen purported members and/or option holders of NuScale LLC filed suit in the U.S. District Court for the District of Oregon against NuScale LLC, Fluor Enterprises, Japan NuScale Innovation, Inc., and Sargent & Lundy Holdings, LLC. The plaintiffs purport to represent a class of individuals who held common units or options to purchase common units in NuScale LLC and seek declaratory relief and damages based on breach of contract and other common law claims. The claims in the complaint are based on amendments to the operating agreement of NuScale LLC in connection with NuScale LLC’s combination with Spring Valley Acquisition Corp. On November 21, 2022, NuScale LLC, along with the other defendants, filed motions to dismiss. Plaintiffs filed a response on January 17, 2023, and NuScale LLC and the other defendants filed a reply on February 14, 2023. A hearing on the motions to dismiss was held on May 17, 2023. On August 3, 2023, the Magistrate Judge issued a report and recommendation that recommended that NuScale LLC’s motion to dismiss be denied. On August 17, 2023, NuScale LLC filed an objection to this report and recommendation. On November 13, 2023, the District Court Judge entered an order accepting the report and recommendation. On December 8, 2023, plaintiffs filed a motion for leave to amend their complaint, and on June 23, 2024, the Court denied this motion. Discovery is now ongoing. While no assurance can be given as to the ultimate outcome of this matter, the Company does not believe it is probable that a loss will be incurred and the Company has not recorded any liability as a result of these actions.
15

NuScale Power Corporation
Notes to the Unaudited Condensed Consolidated Financial Statements
(in thousands, except shares and per share amounts)
Multiple shareholder class action lawsuits were filed in the U.S. District Court for the District of Oregon against the Company and certain of its current or former officers, namely John Hopkins, Chris Colbert, Robert Hamady and Clayton Scott: (1) Sigman v. NuScale Power Corp., et al. (Case No. 23-1689, filed November 15, 2023), and (2) Ryckewaert v. NuScale Power Corp., et al. (Case No. 23-1956, filed December 26, 2023). These lawsuits assert virtually identical allegations and claims and were consolidated before the same judge on February 2, 2024. The lawsuits assert claims under the federal securities laws and allege that the Company and members of management made materially false and/or misleading statements and failed to disclose material adverse facts about the Company’s business, operations and prospects, and specifically about certain of the Company’s agreements with customers. The Court appointed a lead plaintiff and lead counsel, and plaintiffs filed an amended complaint on April 18, 2024 that makes similar allegations as the original complaints. Defendants’ filed a motion to dismiss on June 17, 2024, and plaintiff filed a brief in opposition on August 1, 2024. Shortly thereafter, plaintiffs indicated they intended to seek leave to file a Second Amended Complaint to add allegations relating to the Company’s disclosure about the SEC inquiry disclosed in this Quarterly Report on Form 10-Q under Part II – Other Information, Item 1. Legal Proceedings. Defendants consented to plaintiffs’ request to amend, with the express caveat that defendants believed the proposed amendment to be futile and defendants would move to dismiss any Second Amended Complaint, including any new allegations. On September 20, 2024, plaintiffs filed the Second Amended Complaint, and on November 1, 2024, defendants moved to dismiss. Plaintiffs’ response to Defendants’ motion to dismiss is due December 17, 2024, and Defendants’ reply is due January 24, 2025. While no assurance can be given as to the ultimate outcome of this matter, the Company does not believe it is probable that a loss will be incurred and the Company has not recorded any liability as a result of these actions.
In connection with DOE and UAMPS Award 8935, DOE designated NuScale as a subrecipient to UAMPS for the production of NPM 1, while classifying NuScale as a contractor or subcontractor for NPMs 2-6. As part of DOE’s classification of NuScale as a contractor or subcontractor for NPMs 2-6, DOE noted that should NuScale fail to initiate commercial operation of NPM 1, DOE has the right to demand repayment of the fees invoiced for NPMs 2-6.
16

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of the financial condition and results of operations of NuScale Power Corporation should be read together with our financial statements as of and for the years ended December 31, 2023 and 2022 and our unaudited interim condensed consolidated financial statements as of and for the three and nine months ended September 30, 2024 and 2023, together with related notes thereto. This discussion may contain forward-looking statements based upon current expectations that involve risks and uncertainties. Our actual results may differ materially from those projected in these forward-looking statements as a result of various factors. As used herein, “NuScale,” “the Company,” “us,” “our” or “we” refer to NuScale Power Corporation, together with its consolidated subsidiaries.
Overview
Our mission is to provide scalable advanced nuclear technology to produce electricity, heat and clean water to improve the quality of life for people around the world. We are changing the power that changes the world by creating an energy source that is smarter, cleaner, safer and cost competitive.
Our small modular reactor (“SMR”), known as the NuScale Power Module (“NPM”), provides a scalable power plant solution incorporating enhanced safety, improved affordability and extended flexibility for diverse electrical and process heat applications. Our scalable design provides carbon-free energy at a reduced cost when compared with gigawatt-sized nuclear facilities.
Since our founding in 2007, we have made significant progress towards commercializing the first SMR in the United States. In 2017, we submitted our Design Certification Application (“DCA”) to the U.S. Nuclear Regulatory Commission (“NRC”). On August 28, 2020, the NRC issued its Final Safety Evaluation Report, representing the NRC’s completion of its technical review. On September 11, 2020, the NRC issued its Standard Design Approval (“SDA”) of our NPM and scalable plant design. With this phase of NuScale’s DCA now complete, customers may proceed with plans to develop NuScale power plants with the understanding that the NRC has approved the safety aspects of the NPM and plant design. We expect the Company will continue to experience operating losses and negative operating cash flow until the commercialization of the NPM. On January 19, 2023, the NRC published in the Federal Register a final rule that certifies NuScale’s SMR design for use in the United States, which became effective 30 days after publication.
In January 2023, the Company submitted a SDA Application and the associated licensing topical reports to the NRC for NuScale’s 6-unit 77 MWe NPM design. Once approved, customers in the United States will be able to reference the certified design and SDA for expedited construction and operating licensing of NuScale’s SMR pursuant to 10 CFR Part 52. On July 31, 2023, the NRC formally announced that it has accepted the Company’s SDA Application for formal review. Based on the NRC’s published schedule for SDA Application review, we expect the NRC will complete its review and SDA approval will be received by July 31, 2025.
The Company currently has only one “Class 1” customer: RoPower Nuclear S.A. (“RoPower”), which is a joint venture established by S.N. Nuclearelectrica S.A. (“Nuclearelectrica”) and Nova Power & Gas S.A. In November 2023, we entered into the Release Agreement with CFPP LLC, the Company’s first customer, pursuant to which the Company agreed to terminate the Development Cost Reimbursement Agreement (“DCRA”), as amended, and our Long Lead Material Reimbursement Agreement (“LLM Agreement”). CFPP LLC was receiving funding for approximately 79% of its qualified project costs, including the long-lead materials (“LLM”), under a cooperative agreement with the Department of Energy (“DOE”). Under the Release Agreement, we agreed to repay CFPP LLC’s Net Development Costs. Upon final settlement of the LLM Agreement, and once DOE is compensated for its investment in the LLM (stemming from DOE’s funding under its cost share agreement with CFPP LLC), NuScale will obtain all rights and obligations associated with the LLM.
Revenue Recognition
As we continue to transition from a R&D company toward the commercialization of our SMR, we continue to expand our array of products and services. During the third fiscal quarter of 2024, the Company entered into a revenue generating agreement with a customer, structured as a fixed price contract with variable consideration. Under this fixed price contract, all amounts currently collected are deferred and included in Customer deposit on the condensed consolidated balance sheet, with revenue to be recognized as performance obligations are achieved.
17

Results of Operations

(in thousands) |  | Three Months Ended September 30, |  | Nine Months Ended September 30,
|  | 2024 |  | 2023 |  | 2024 |  | 2023
Revenue |  | $ | 475 |  |  | $ | 6,950 |  |  | $ | 2,821 |  |  | $ | 18,250 |
Cost of sales |  | (295) |  |  | (5,940) |  |  | (1,880) |  |  | (15,121) |
Gross Margin |  | 180 |  |  | 1,010 |  |  | 941 |  |  | 3,129 |
Research and development expenses |  | 12,160 |  |  | 63,725 |  |  | 37,447 |  |  | 118,227 |
General and administrative expenses |  | 17,021 |  |  | 16,402 |  |  | 53,207 |  |  | 47,420 |
Other expenses |  | 12,018 |  |  | 13,799 |  |  | 37,157 |  |  | 41,991 |
Loss From Operations |  | (41,019) |  |  | (92,916) |  |  | (126,870) |  |  | (204,509) |
Sponsored cost share |  | 660 |  |  | 20,774 |  |  | 6,504 |  |  | 54,984 |
Change in fair value of warrant liabilities |  | (7,191) |  |  | 11,076 |  |  | (52,969) |  |  | 17,167 |
Interest income |  | 2,008 |  |  | 2,738 |  |  | 5,275 |  |  | 8,686 |
Loss Before Income Taxes |  | $ | (45,542) |  |  | $ | (58,328) |  |  | $ | (168,060) |  |  | $ | (123,672) |
Foreign income taxes |  | 12 |  |  | — |  |  | 12 |  |  | — |
Net Loss |  | (45,554) |  |  | (58,328) |  |  | (168,072) |  |  | (123,672) |

Comparison of the Three Months Ended September 30, 2024 and 2023
Revenue and Cost of Sales
The decrease in revenue and cost of sales was attributable to the loss of the contract with CFPP LLC.
Research and Development
R&D expenses decreased as a result of $2.1 million in lower compensation costs associated with our transition from a R&D-based company to a commercial company, while we also had lower professional fees of $49.4 million which is comprised of a $34.5 million CFPP LLC contract termination fee, combined with various internal cost optimizing measures.
Sponsored Cost Share
Sponsored cost share decreased due to decreased DOE funding and the loss of the CFPP LLC contract.
Change in Fair Value of Warrant Liabilities
The change resulted from an increase in the Company’s warrant price during the three months ended September 30, 2024, while the price dropped during the same period in the previous fiscal year.
Comparison of the Nine Months Ended September 30, 2024 and 2023
Changes in Presentation
For the nine months ended September 30, 2023, amounts totaling $1.9 million were reclassified out of Other expenses and into R&D expenses to conform to the current year presentation.
Revenue and Cost of Sales
The decrease in revenue and cost of sales was attributable to the loss of the contract with CFPP LLC.
Research and Development
R&D expenses decreased as a result of $6.0 million in lower compensation costs associated with our transition from a R&D-based company to a commercial company, along with lower professional fees of $74.5 million, which includes a $34.5 million CFPP LLC contract termination fee, combined with various internal cost optimization measures.
18

General and Administrative
G&A expenses increased due to higher strategic marketing expenses in the amount of $7.4 million, partially offset by lower professional fees and management successfully executing their strategy for controlling costs related to nonessential items.
Other
Other expenses decreased as a result of lower equity-based compensation in the amount of $2.2 million along with savings on nonessential expenses management has identified and eliminated.
Sponsored Cost Share
Sponsored cost share decreased as a result of the loss of the contract with CFPP LLC and decreased DOE funding in the current year.
Change in Fair Value of Warrant Liabilities
The change resulted from an increase in the Company’s warrant price during the nine months ended September 30, 2024, while the price decreased during the same period in the prior year.
Liquidity and Capital Resources
During the three months ended September 30, 2024, the ATM Program generated gross proceeds of $32.0 million and net proceeds of $31.2 million, while for three and nine months ended September 30, 2023, the ATM Program generated gross and net proceeds of $8.3 million and $7.9 million, respectively. During the nine months ended September 30, 2024 the ATM Program generated gross and net proceeds of $106.5 million and $103.8 million, respectively. As of September 30, 2024, we have 2,601,042 shares of Class A common stock authorized and available under the ATM Program at an aggregate sales price of up to $33.1 million.
Subsequent to September 30, 2024, the Company issued and sold 2,601,042 shares of Class A common stock under the ATM Program for the gross and net proceeds of $32.5 million and $31.6 million, respectively.
Since NuScale’s inception, we have incurred significant operating losses and have an accumulated deficit of $302.1 million, with negative operating cash flows. As of September 30, 2024, we had cash and cash equivalents of $111.6 million, short-term investments of $45.0 million and restricted cash of $5.1 million with no debt. Historically, our primary sources of cash included investment capital, DOE and other government sponsored cost share agreements to support the advancement of the Company’s SMR technology both domestically and abroad. As we transition from a focus on research and development to commercialization of our technology, the Company is focusing on commercial contracts that generate revenue. While we believe we have sufficient funds to reach commercialization of our NPM, certain costs are not reasonably estimable at this time, and we may require additional funding, which may not be available on terms acceptable to us or at all. Our projections anticipate certain customer-sourced income that is not assured and DOE funds which are subject to Congressional appropriations and dependent on the President signing it into law.
On January 5, 2024, NuScale announced a plan to reduce the Company’s workforce by 154 full time employees, or 28%, in order to continue our transition from a R&D-based company to a commercial company. This resulted in a one-time charge of $3.2 million during the nine months ended September 30, 2024.
Subsequent to September 30, 2024, the Company executed a revenue generating agreement with Fluor, whereby NuScale will provide engineering and design services in support of Phase 2 Front-End Engineering and Design for a VOYGR TM-6 Nuclear Power Generation project.
As a result of the cost-optimization plans implemented by management, the utilization of our ATM Program and the execution of customer contracts, we believe we will have sufficient funds available to cover required R&D activities and operating cash needs for the next twelve months. Further, management plans to prudently manage its expenses and cash reserves into the future, including beyond the next twelve months, recognizing the need to secure additional customer commitments to support long-term operations. For additional information regarding these risk factors, see the Company’s 2023 Form 10-K.
19

Comparison of Cash Flows for the Nine Months Ended September 30, 2024 and 2023
The following table sets forth the primary sources and uses of cash and cash equivalents for the periods presented below:

|  | Nine Months Ended September 30,
(in thousands) |  | 2024 |  | 2023
Net Cash Used in Operating Activities |  | $ | (82,249) |  |  | $ | (110,042) |
Net Cash (Used) Provided by Investing Activities |  | (44,805) |  |  | 48,326 |
Net Cash Provided by Financing Activities |  | 118,417 |  |  | 14,133 |
Net change in cash and cash equivalents (A) |  | $ | (8,637) |  |  | $ | (47,583) |
(A) Includes $5,100 in restricted cash |  |  |  |

Cash Flows used in Operating Activities
Our cash used in operations improved during the nine months ended September 30, 2024 due to the receipt of the customer deposit and lower strategic marketing spend.
Cash Flows (used) provided by Investing Activities
During the nine months ended September 30, 2024 the Company purchased short-term investments totaling $45.0 million, while during the same period in the prior year, the Company sold $50.0 million in short-term investments.
Cash Flows provided by Financing Activities
During both the nine months ended September 30, 2024 and 2023, net cash provided by financing activities consisted of proceeds from the utilization of our ATM Program and the exercise of stock options.
Capital Resources
Under the Release Agreement, the Company is required to have credit support to fund the amount of its potential reimbursement of demobilization and wind down costs with CFPP LLC. This account is identified as Restricted cash in the amount of $5.1 million on the accompanying condensed consolidated balance sheet and acts as collateral for the $5.0 million letter of credit outstanding at September 30, 2024.
In connection with DOE and UAMPS Award 8935, DOE designated NuScale as a subrecipient to UAMPS for the production of NPM 1, while classifying NuScale as a contractor or subcontractor for NPMs 2-6. As part of DOE’s classification of NuScale as a contractor or subcontractor for NPMs 2-6, DOE noted that should NuScale fail to initiate commercial operation of NPM 1, DOE has the right to demand repayment of the fees invoiced for NPMs 2-6.
Recent Accounting Pronouncements
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740) – Improvements to Income Tax Disclosures (ASU 2023-09). ASU 2023-09 requires that an entity, on an annual basis, disclose additional income tax information, primarily related to the rate reconciliation and income taxes paid. The amendment in the ASU is intended to enhance the transparency and decision usefulness of income tax disclosures. The ASU’s amendments are effective for annual periods beginning after December 15, 2024. The Company is currently evaluating the impact that adoption of ASU 2023-09 will have on our condensed consolidated financial statements.
In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280) – Improvements to Reportable Segment Disclosures. ASU 2023-07 requires annual and interim disclosures that are expected to improve reportable segment disclosures, primarily through enhanced disclosures about significant segment expenses. The provisions of ASU 2023-07 are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating ASU 2023-07 to determine its impact on the Company’s disclosures, however, the Company does not expect ASU 2023-07 to have a material impact.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
20

There have been no material changes from the discussion of the Company’s market risk in Part I, Item 7A., Quantitative and Qualitative Disclosures About Market Risk, of the Company’s 2023 Form 10-K.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of September 30, 2024, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial officer have concluded that, as of the evaluation date, our disclosure controls and procedures were effective as of September 30, 2024. Accordingly, management believes that the financial statements included in this Form 10-Q present fairly in all material respects our financial position, results of operations and cash flows for the period presented.
Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.
21

Part II - Other Information
Item 1. Legal Proceedings
In the regular course of business, the Company is involved in various legal proceedings and claims incidental to the normal course of business. Other than as disclosed immediately below, the Company does not believe that any legal claims are material to the Company. Management does not believe that resolution of any of these matters will materially affect the Company’s financial position or results of operations.
On September 19, 2022, thirteen purported members and/or option holders of NuScale LLC filed suit in the U.S. District Court for the District of Oregon against NuScale LLC, Fluor Enterprises, Japan NuScale Innovation, Inc., and Sargent & Lundy Holdings, LLC. The plaintiffs purport to represent a class of individuals who held common units or options to purchase common units in NuScale LLC and seek declaratory relief and damages based on breach of contract and other common law claims. The claims in the complaint are based on amendments to the operating agreement of NuScale LLC in connection with NuScale LLC’s combination with Spring Valley Acquisition Corp. On November 21, 2022, NuScale LLC, along with the other defendants, filed motions to dismiss. Plaintiffs filed a response on January 17, 2023, and NuScale LLC and the other defendants filed a reply on February 14, 2023. A hearing on the motions to dismiss was held on May 17, 2023. On August 3, 2023, the Magistrate Judge issued a report and recommendation that recommended that NuScale LLC’s motion to dismiss be denied. On August 17, 2023, NuScale LLC filed an objection to this report and recommendation. On November 13, 2023, the District Court Judge entered an order accepting the report and recommendation. On December 8, 2023, plaintiffs filed a motion for leave to amend their complaint, and on June 23, 2024, the Court denied this motion. Discovery is now ongoing. While no assurance can be given as to the ultimate outcome of this matter, the Company does not believe it is probable that a loss will be incurred and the Company has not recorded any liability as a result of these actions.
Multiple shareholder class action lawsuits were filed in the U.S. District Court for the District of Oregon against the Company and certain of its current or former officers, namely John Hopkins, Chris Colbert, Robert Hamady and Clayton Scott: (1) Sigman v. NuScale Power Corp., et al. (Case No. 23-1689, filed November 15, 2023), and (2) Ryckewaert v. NuScale Power Corp., et al. (Case No. 23-1956, filed December 26, 2023). These lawsuits assert virtually identical allegations and claims and were consolidated before the same judge on February 2, 2024. The lawsuits assert claims under the federal securities laws and allege that the Company and members of management made materially false and/or misleading statements and failed to disclose material adverse facts about the Company’s business, operations and prospects, and specifically about certain of the Company’s agreements with customers. The Court appointed a lead plaintiff and lead counsel, and plaintiffs filed an amended complaint on April 18, 2024 that makes similar allegations as the original complaints. Defendants’ filed a motion to dismiss on June 17, 2024, and plaintiff filed a brief in opposition on August 1, 2024. Shortly thereafter, plaintiffs indicated they intended to seek leave to file a Second Amended Complaint to add allegations relating to the Company’s disclosure about the SEC inquiry disclosed in the next paragraph of this Quarterly Report on Form 10-Q. Defendants consented to plaintiffs’ request to amend, with the express caveat that defendants believed the proposed amendment to be futile and defendants would move to dismiss any Second Amended Complaint, including any new allegations. On September 20, 2024, plaintiffs filed the Second Amended Complaint, and on November 1, 2024, defendants moved to dismiss. Plaintiffs’ response to Defendants’ motion to dismiss is due December 17, 2024, and Defendants’ reply is due January 24, 2025. While no assurance can be given as to the ultimate outcome of this matter, the Company does not believe it is probable that a loss will be incurred and the Company has not recorded any liability as a result of these actions.
In December 2023, the Company received a voluntary request from the SEC’s Denver Regional Office for information relating to its employment, severance, and confidentiality agreements, which the Company understood to be a part of a broader inquiry involving multiple companies related to the SEC’s whistleblower provisions. The Company responded in January 2024 and had no further communications with the SEC. On July 30, 2024, the Company contacted the SEC following publication of an article by Hunterbrook Media. On July 31, 2024, the SEC made follow up requests for additional information relating to the December 2023 request. The Company is in the process of responding to those requests and intends to fully cooperate with the SEC. The Company cannot predict the timing or outcome of the SEC’s investigation at this time.
Item 1A. Risk Factors
We are and may become involved in litigation that may materially adversely affect us.
We are currently named in a number of purported class action lawsuits (see “Legal Proceedings”), and from time to time, we are and may become involved in various legal proceedings relating to other matters, including intellectual property, commercial, product liability, employment, class action, whistleblower and other litigation and claims, and governmental and other regulatory investigations and proceedings, such as the SEC’s current request for information regarding our
22

employment, severance, and confidentiality agreements. Such matters can be time-consuming, divert management’s attention and resources from the operation of our business and cause us to incur significant expenses or liability or require us to change our business practices.
One of the existing shareholder class action lawsuits claims in part that NuScale LLC breached its prior LLC operating agreement or breached a duty of good faith and fair dealing in amending the LLC operating agreement in the Transaction without obtaining the consent of former common unit holders of NuScale LLC as a separate class. This class action lawsuit claims in part that the conversion of preferred units to common units, which occurred in conjunction with the merger, was inequitable to common unit holders. Plaintiffs are now seeking to amend their complaint to add a claim that this conversion itself breached the operating agreement.
The other shareholder class action lawsuit claims that NuScale and members of management made materially false and/or misleading statements and failed to disclose material adverse facts about the Company’s business, operations and prospects, and specifically about certain of the Company’s agreements with customers. While two causes of action were filed, these lawsuits have been consolidated before the same judge in the federal district court in Oregon.
While we disagree with all of the plaintiffs’ claims included in the class action lawsuits, the risk of loss if plaintiffs prevail would be material to the Company. Because of the potential risks, expenses and uncertainties of litigation and investigations, we may, from time to time, settle disputes and other proceedings, even where we believe that we have meritorious claims or defenses. Because litigation and investigations are inherently unpredictable, we cannot assure you that the results of any of these actions will not have a material adverse effect on our business.
Please see the 2023 Form 10-K for a complete list of our risk factors.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Not applicable
Item 3. Defaults Upon Senior Securities
Not applicable
Item 4. Mine Safety Disclosures
Not applicable
Item 5. Other Information
Rule 10b5-1 Trading Plans
In August 2024, we proposed to certain employees, including officers, with restricted stock units (“RSUs”) that they instruct the agent who administers our 2022 Long-Term Incentive Plan to promptly sell shares of Class A common stock sufficient to cover tax withholding obligations arising from the vesting and settlement of the RSUs (a “10b5-1(c) Trading Instruction for Eligible Sell-to-Cover Transaction”). With respect to any eligible sell-to-cover transactions before the expiration of the cooling off periods specified in Rule 10b5-1(c), the instruction is intended to be a “non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K, and with respect to eligible sell-to-cover transactions after the cooling off periods specified in Rule 10b5-1(c), the instruction is intended to be a “Rule 10b5-1 trading arrangement” as defined in Item 408(a) of Regulation S-K and satisfy the affirmative defense of Rule 10b5-1(c). There is no durational limit to, or specified number of shares to be sold pursuant to, these instructions. During the three months ended September 30, 2024, Andrea Lachenmayr, Interim General Counsel, signed a 10b5-1(c) Trading Instruction for Eligible Sell-to-Cover Transaction and provided it to the agent on August 13, 2024.
During the three months ended September 30, 2024, the Company had four officers adopt Rule 10b5-1 trading arrangements. These trading arrangements are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), and do not have any limitation on their duration or the aggregate number of securities that may be purchased or sold pursuant to them. John Hopkins, Chief Executive Officer, entered into a plan on September 9, 2024, R. Ramsey Hamady, Chief Financial Officer, entered into a plan on September 10, 2024, Jackie Engel, Interim Vice President of Accounting, adopted a plan on August 30, 2024, and Karin Feldman, Senior Vice President of Product and Project Delivery, adopted a plan on August 13, 2024.
23

Item 6. Exhibits and Financial Statements Schedules
(a)Exhibits.

Exhibit Number |  | Description
3.1 |  | Certificate of Incorporation of NuScale Power Corporation (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on May 5, 2022) and Certificate of Amendment to Certificate of Incorporation (incorporated by reference to Exhibit 4.1 to the Registration Statement on Form S-8 filed by the Registrant on September 1, 2023
3.2 |  | Bylaws of NuScale Power Corporation (incorporated by reference to Exhibit 3.2 to the Current Report on Form 8-K filed on May 5, 2022)
4.1 |  | Specimen Warrant Certificate (incorporated by reference to Exhibit 4.3 to the Registration Statement on Form S-1 filed by the Registrant on November 20, 2020)
4.2 |  | Warrant Agreement between Continental Stock Transfer & Trust Company and Spring Valley Acquisition Corp., dated November 23, 2020 (incorporated by reference to Annex L to the Proxy Statement/ Prospectus filed on April 8, 2022)
31.1 |  | Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a)
31.2 |  | Certification of Principal Financial Officer pursuant to Rule 13a-14(a)/15d-14(a)
32.1 |  | Certification of Chief Executive Officer pursuant to Rule 13a-14(d)/15d-14(d)
32.2 |  | Certification of Principal Financial Officer pursuant to Rule 13a-14(d)/15d-14(d)
10.1 |  | Task Order No.: R1MA-P2-OFS-90-K200, dated October 3, between the Company and Fluor Transworld Services, Inc., - (portions of this exhibit have been omitted) (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on October 9, 2024)
101 .INS |  | XBRL Instance Document
101.SCH |  | XBRL Taxonomy Extension Schema Document
101.CAL |  | XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF |  | XBRL Taxonomy Extension Definition Linkbase Document
101.LAB |  | XBRL Taxonomy Extension Label Linkbase Document
101.PRE |  | XBRL Taxonomy Extension Presentation Linkbase Document
104 |  | Cover Page Interactive Data File (formatted as Inline XBRL).

__________________________________________
24

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

| NuScale Power Corporation
Date | By: | /s/ John Hopkins
November 8, 2024 | Name: | John Hopkins
| Title: | Chief Executive Officer
Date | By: | /s/ R. Ramsey Hamady
November 8, 2024 | Name | R. Ramsey Hamady
| Title: | Chief Financial Officer

25